▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3018 by analyst upside · 2026-11-12
SNY
Sanofi
Healthcare · Market Cap $116B · P/E 24.0x
ANALYST PRICE TARGET
+13.4%
implied upside to consensus target
Current Price $48.43
Consensus Target $54.92
Bull Target $63.0
Bear Target $45.0
Analysts Covering 9
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
3
Hold
4
Sell
0
52-Week Low $39.07
52-Week High $52.68
YTD Return +6.0%
FUNDAMENTALS
Market Cap $116B
P/E Ratio (TTM) 24.0x
Forward P/E 8.9x
EPS (TTM) $2.02
PEG Ratio 1.77
Dividend Yield 5.02%
Revenue (TTM) $51.0B
Profit Margin 8.2%
52-WEEK RANGE
52-Week Low $39.07
52-Week High $52.68
Current Price $48.43
Bear Target $45.0
Bull Target $63.0
● Now $48.43 ● Target $54.92
TRADING DATA
Avg Volume 3.4M
YTD Return +6.0%
Analyst Count 9
Consensus Buy
Upside to Target +13.4%
Last Updated 2026-11-12

ANALYST SUMMARY

Sanofi (SNY) is currently trading at $48.43 with a Wall Street consensus price target of $54.92, implying potential upside of 13.4% over the next 12 months. 9 analysts currently cover SNY, with a consensus rating of Buy - 56% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $63.0, while the most cautious has a target of $45.0.

SNY operates in the Healthcare sector with a market capitalisation of $116B. The stock is up 6.0% year-to-date and is currently trading near the upper end of its 52-week range of $39.07 – $52.68.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SNY, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS ↓ Downgrade
Buy → Neutral 2026-01-16 33% win rate (6 calls)
Barclays ↓ Downgrade
Overweight → Equal-Weight 2026-01-06 Building track record
Guggenheim ↓ Downgrade
Buy → Neutral 2025-12-09 62% win rate (8 calls)
JP Morgan ↓ Downgrade
Overweight → Neutral 2025-12-08 43% win rate (7 calls)
Morgan Stanley ↑ Upgrade
Equal-Weight → Overweight 2025-09-08 Building track record
Deutsche Bank ↑ Upgrade
Hold → Buy 2025-09-02 Building track record
JP Morgan ↑ Upgrade
Neutral → Overweight 2025-08-08 43% win rate (7 calls)
Goldman Sachs ● Initiated
Neutral 2025-03-21 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
56
out of 100
Coverage depth
18/30
Consensus clarity
23/30
Vote unanimity
5/25
Rating stability
10/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →